Aprepitant versus dexamethasone for delayed emesis: What is the role of the 5-hydroxytryptamine type 3 receptor antagonist palonosetron?

Luigi Celio, Filippo De Braud, Matti Aapro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2185-2186
Number of pages2
JournalJournal of Clinical Oncology
Issue number20
Publication statusPublished - Jul 10 2014

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this